Gynecology & Obstetrics Case report Open Access

  • ISSN: 2471-8165
  • Journal h-index: 7
  • Journal CiteScore: 0.44
  • Journal Impact Factor: 1.86
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Mini Review - (2023) Volume 9, Issue 3

Adenomyosis: Understanding a Complex Uterine Disorder
Constance Maudot*
 
Department of Reproductive Medicine, University of Ghent, Ghent, Belgium
 
*Correspondence: Constance Maudot, Department of Reproductive Medicine, University of Ghent, Ghent, Belgium, Email:

Received: 29-Apr-2023, Manuscript No. ipgocr-23-16674; Editor assigned: 01-May-2023, Pre QC No. IPGOCR-23-16674 (PQ); Reviewed: 12-May-2023, QC No. IPGOCR-23-16674 (Q); Revised: 19-May-2023, Manuscript No. IPGOCR-23-16674 (R); Published: 29-May-2023, DOI: 10.36648/2471-8165.9.3.19

Abstract

Adenomyosis is a gynecological condition that affects many women worldwide. It is characterized by the presence of endometrial tissue within the muscular walls of the uterus, causing various symptoms and challenges. This condition often goes undiagnosed or misdiagnosed, leading to prolonged suffering for many individuals. In this article, we will delve into the details of adenomyosis, exploring its causes, symptoms, diagnosis, treatment options and the impact it has on women's lives. Adenomyosis occurs when the endometrial tissue, which normally lines the uterus, grows into the muscular walls of the uterus. This abnormal growth leads to the enlargement and thickening of the uterus, resulting in painful and heavy periods. The exact cause of adenomyosis remains unknown, but several theories suggest hormonal imbalances, inflammation and genetic factors as possible contributors. Adenomyosis primarily affects women in their 40s and 50s, but it can occur in women of any age.

Keywords

Adenomyosis; Diagnosis; Hysterectomy

Introduction

Heavy or prolonged menstrual bleeding: Women with adenomyosis often experience heavy and prolonged periods, accompanied by severe cramping. This excessive bleeding can lead to anemia in some cases. Adenomyosis causes intense uterine contractions during menstruation, resulting in debilitating cramps that may radiate to the lower back and thighs. Chronic pelvic pain outside of menstruation is a common symptom of adenomyosis. The pain can range from mild discomfort to severe and can impact daily activities and quality of life. Some women with adenomyosis may experience pain during sexual intercourse, known as dyspareunia, due to the inflammation and enlargement of the uterus. Adenomyosis causes the uterus to become larger and tender to touch. This enlargement can sometimes be felt during a pelvic examination [1].

Literature Review

Diagnosing adenomyosis can be challenging, as its symptoms often overlap with other gynecological conditions like endometriosis and fibroids. The doctor will review the patient's medical history, including symptoms and menstrual patterns. A pelvic examination may be performed to check for an enlarged uterus. Ultrasound is commonly used to visualize the uterus and detect any abnormalities. However, Magnetic Resonance Imaging (MRI) may be necessary for a more accurate diagnosis, as it provides detailed images of the uterine structure. In some cases, a tissue sample (biopsy) may be taken from the uterine lining to confirm the presence of adenomyosis and rule out other conditions. Treatment for adenomyosis depends on various factors such as the severity of symptoms, age, desire for future pregnancy and overall health [2].

Discussion

Over-the-counter pain relievers like Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) can help alleviate menstrual pain and cramping. In more severe cases, the doctor may prescribe stronger pain medications. Hormonal treatments, such as birth control pills, hormonal Intrauterine Devices (IUDs), or progesterone therapy, can help regulate menstrual cycles, reduce bleeding and relieve pain associated with adenomyosis. Adenomyosis is a common yet often overlooked gynecological condition that affects millions of women worldwide. It occurs when the tissue that normally lines the uterus, known as the endometrium, grows into the muscular wall of the uterus, causing various symptoms and complications. This article aims to provide a comprehensive understanding of adenomyosis by exploring its causes, symptoms, diagnosis and available treatment options. The exact cause of adenomyosis remains unknown, but several theories have been proposed. One possibility is that it results from the backward movement of endometrial tissue through the fallopian tubes into the uterine wall. Hormonal imbalances, such as an excess of estrogen relative to progesterone, may also contribute to the development of adenomyosis. Other potential risk factors include previous uterine surgeries, such as cesarean sections or fibroid removal and advanced maternal age [3].

Adenomyosis can manifest differently in each woman, with some experiencing mild symptoms and others facing significant challenges. It is important to note that some women with adenomyosis may not experience any symptoms at all, while others may have a combination of symptoms that can significantly impact their quality of life. Diagnosing adenomyosis can be challenging due to its similarity to other gynecological conditions. A physical examination may reveal an enlarged and tender uterus. This imaging technique allows for the visualization of the uterus and can help identify characteristic changes in the uterine wall. MRI can provide detailed images of the uterus and help distinguish adenomyosis from other conditions. In some cases, a tissue sample may be obtained through a procedure called hysteroscopy to confirm the diagnosis. Treatment for adenomyosis depends on the severity of symptoms, a woman's age, desire for future pregnancies and overall health [4].

Over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can help alleviate menstrual cramps and pelvic pain. Birth control pills, hormonal intrauterine devices (IUDs), or progestin-only therapy may be prescribed to help regulate the menstrual cycle and reduce symptoms. This minimally invasive procedure involves injecting small particles into the arteries that supply blood to the uterus, reducing the blood flow and shrinking the adenomyosis. In this procedure, the lining of the uterus is destroyed or removed to alleviate heavy bleeding. In severe cases or for women who no longer desire future pregnancies, a hysterectomy (removal of the uterus) may be recommended as a definitive treatment [5,6].

Conclusion

Adenomyosis is a complex gynecological condition that can significantly impact a woman's quality of life. While the exact cause is still unknown, understanding its risk factors and symptoms is crucial for early detection and management. With advancements in diagnostic techniques and a range of treatment options available. Adenomyosis is a complex gynecological condition that affects numerous women worldwide. Despite its prevalence, adenomyosis often goes undiagnosed or overlooked, leading to prolonged suffering and decreased quality of life for many women. By understanding the causes, symptoms, diagnosis and treatment options for adenomyosis, both healthcare providers and affected individuals can work together to improve the management and outcomes of this condition.

Acknowledgement

None.

Conflict of Interest

The author has no conflicts of interest to declare.

References

  1. Garcıa P, Nieto A, Sanchez MA, Pizarro M, Flores JM (2004) Expression of αv, α4, α5 and β3 integrin subunits, fibronectin and vitronectin in goat peri-implantation. Anim Reprod Sci 80(12):91-100.
  2. [Google Scholar], [Crossref], [Indexed at]

  3. Fayazi M, Boroujeni MB, Salehnia M, Khansarinejad B (2014) Ovarian stimulation by exogenous gonadotropin decreases the implantation rate and expression of mouse blastocysts integrins. Iran Biomed J 18(1):8.
  4. [Google Scholar], [Crossref], [Indexed at]

  5. Carrarelli P, Yen CF, Funghi L, Arcuri F, Tosti C, et al. (2017) Expression of inflammatory and neurogenic mediators in adenomyosis: A pathogenetic role. Reprod Sci 24(3):369-375.
  6. [Google Scholar], [Crossref], [Indexed at]

  7. Benagiano G, Brosens I, Habiba M (2014) Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update 20(3):386-402.
  8. [Google Scholar], [Crossref], [Indexed at]

  9. Ishikawa M, Nakata T, Yaginuma Y, Nishiwaki K, Goishi K, et al. (1993) Expression of superoxide dismutase (SOD) in adenomyosis. Am J Obstet Gynecol. 169(3):730-4.
  10. [Google Scholar], [Crossref], [Indexed at]

  11. Orazov MR, Radzinsky VE, Nosenko EN, Khamoshina MB, Dukhin AO, et al. (2017) Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis. Gynecol Endocrinol 33(1):44-46.
  12. [Google Scholar], [Crossref], [Indexed at]

Citation: Maudot C (2023) Adenomyosis: Understanding a Complex Uterine Disorder. Gynecol Obstet Case Rep. Vol.9 No.3:19.

Copyright: © Maudot C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.